Evidence map›Paper›PMID 40535393›Full record

ArticleCureus2025

Rare Case of Primary Bone Lymphoma.

Madeline L Fudala, Imad Karam, Aye M Thida, Imran Khan, Rachelle Hamadi, Natasha Macapagal-Brown, Raavi Gupta, Mohan Preet

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Madeline L FudalaHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Imad KaramHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Aye M ThidaHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Imran KhanHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Rachelle HamadiHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Natasha Macapagal-BrownPathology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Raavi GuptaPathology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.
Mohan PreetHematology and Oncology, State University of New York, Downstate Health Sciences University, Brooklyn, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary bone lymphoma (PBL) is a rare entity defined as a lymphoid neoplasm of bone that occurs in the bone without involvement of lymph nodes or other extranodal sites. In this report, we present a case of an elderly female with PBL who presented with regional lymphadenopathy and cutaneous lesions mimicking the primary cutaneous diffuse B-cell lymphoma (PCDBCL), leg type. This review describes the case of a 73-year-old female with primary bone lymphoma who presented with cutaneous lesions and regional lymphadenopathy. She was initially diagnosed with Paget's disease of bone but ultimately presented to the emergency room with a pathologic fracture of the left tibia and painful overlying cutaneous lesions. Imaging studies, including X-ray and computed tomography (CT) scans, along with a tibial biopsy, revealed findings consistent with PBL, characterized by large lymphoid cells that were positive for CD10, CD20, and Bcl6, with a high Ki-67 index. The diagnosis was confirmed despite the atypical cutaneous involvement. Due to her age, low-performance status, and extranodal disease, the patient was classified as high-intermediate risk according to the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI) criteria. The presence of extranodal involvement also placed her at intermediate risk for central nervous system (CNS) disease. The clinical presentation of PBLs is often nonspecific, and diagnostic criteria noted in the literature vary, making for a difficult diagnosis in clinical practice. To our knowledge, this patient is the first documented case of PBL with concurrent cutaneous manifestations and regional lymph node involvement. This case report and literature review investigate the possibility of PBLs presenting with lesions extending beyond the initial area of bony involvement.

Indexed as

cutaneous involvementdiffuse large b lymphomaextranodal diffuse large b-cell lymphomaprimary bone lymphomaprimary diffuse large b-cell lymphomarare lymphoma

Identifiers

PMID40535393
PMCPMC12176316

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.